These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 22867060

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased COX-2 expression in human vaginal epithelial cells exposed to nonoxynol-9, a vaginal contraceptive microbicide that failed to protect women from HIV-1 infection.
    Zalenskaya IA, Cerocchi OG, Joseph T, Donaghay MA, Schriver SD, Doncel GF.
    Am J Reprod Immunol; 2011 Jun; 65(6):569-77. PubMed ID: 21241401
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
    Yang J, Li L, Jin H, Tan S, Qiu J, Yang L, Ding Y, Jiang ZH, Jiang S, Liu S.
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.
    Vibholm L, Reinert LS, Søgaard OS, Paludan SR, Østergaard L, Tolstrup M, Melchjorsen J.
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1404-11. PubMed ID: 22867119
    [Abstract] [Full Text] [Related]

  • 7. PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ, Samuel P, Uckun FM.
    Biol Reprod; 2004 Dec; 71(6):2037-47. PubMed ID: 15306558
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
    Kaul R, Pettengell C, Sheth PM, Sunderji S, Biringer A, MacDonald K, Walmsley S, Rebbapragada A.
    J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current and future microbicide approaches aimed at preventing HIV infection in women.
    Pozzetto B, Delézay O, Brunon-Gagneux A, Hamzeh-Cognasse H, Lucht F, Bourlet T.
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):167-83. PubMed ID: 22339191
    [Abstract] [Full Text] [Related]

  • 14. Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.
    Keller MJ, Herold BC.
    Am J Reprod Immunol; 2006 Feb; 56(5-6):356-63. PubMed ID: 17076680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities.
    Hladik F, Doncel GF.
    Antiviral Res; 2010 Dec; 88 Suppl 1(Suppl 1):S3-9. PubMed ID: 21109065
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.